EU Checks Pharma’s Appetite To Share Market Launch Intentions
Executive Summary
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
You may also be interested in...
EU Wants To Hear Pharma Firms' Plans For New Product Launches
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU Unveils Ambitions To ‘Future-Proof’ Entire Drug Regulatory Framework
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.